Krsnaa Diagnostics Q2 FY27 consolidated revenue Rs 271.00 cr, PAT Rs 24.60 cr
Krsnaa Diagnostics’ consolidated revenue from operations rose to Rs 271.00 cr in Q2 FY27, with PAT at Rs 24.60 cr versus Rs 23.90 cr in Q2 FY26.
Key takeaways
- Revenue from operations Rs 271.00 cr in Q2 FY27 vs Rs 206.00 cr in Q2 FY26
- Total expenses increased to Rs 199.00 cr from Rs 145.80 cr a year earlier
- EBITDA Before CSR & ESOP was Rs 71.90 cr vs Rs 60.20 cr in Q2 FY26
- PBT stood at Rs 32.80 cr in Q2 FY27 vs Rs 31.60 cr in Q2 FY26
- PAT was Rs 24.60 cr in Q2 FY27 compared with Rs 23.90 cr in Q2 FY26
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 271.00 cr | Rs 206.00 cr | +31.6% |
| PAT | Rs 24.60 cr | Rs 23.90 cr | +2.9% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 9.08% of revenue, down 252 bps from 11.60%.
- Total expenses rose 36.5% while revenue rose 31.6%.
Key consolidated numbers (statement of financial results – Q2 FY27 vs Q2 FY26)
- Revenue from operations: Rs 271.00 cr (Q2 FY26: Rs 206.00 cr)
- Total expenses: Rs 199.00 cr (Q2 FY26: Rs 145.80 cr)
- EBITDA Before CSR & ESOP: Rs 71.90 cr (Q2 FY26: Rs 60.20 cr)
- CSR and ESOP: Rs 0.80 cr (Q2 FY26: Rs 1.00 cr)
- EBITDA: Rs 71.10 cr (Q2 FY26: Rs 59.20 cr)
- Finance costs: Rs 15.50 cr (Q2 FY26: Rs 8.20 cr)
- Depreciation: Rs 29.10 cr (Q2 FY26: Rs 23.60 cr)
- Other income: Rs 6.20 cr (Q2 FY26: Rs 4.20 cr)
- PBT: Rs 32.80 cr (Q2 FY26: Rs 31.60 cr)
- Tax: Rs 8.20 cr (Q2 FY26: Rs 7.70 cr)
- PAT: Rs 24.60 cr (Q2 FY26: Rs 23.90 cr)
According to the consolidated statement of financial results presented in the investor presentation, Krsnaa Diagnostics’ revenue from operations for the quarter ended 30 September 2026 (Q2 FY27) was Rs 271.00 cr, up from Rs 206.00 cr in the corresponding quarter a year earlier (Q2 FY26). Total expenses increased to Rs 199.00 cr from Rs 145.80 cr over the same period.
EBITDA Before CSR & ESOP for Q2 FY27 stood at Rs 71.90 cr, compared with Rs 60.20 cr in Q2 FY26. After accounting for CSR and ESOP expenses of Rs 0.80 cr (Q2 FY26: Rs 1.00 cr), reported EBITDA was Rs 71.10 cr versus Rs 59.20 cr a year ago. Finance costs rose to Rs 15.50 cr from Rs 8.20 cr, while depreciation increased to Rs 29.10 cr from Rs 23.60 cr. Other income for the quarter was Rs 6.20 cr, compared with Rs 4.20 cr in Q2 FY26.
After these items, profit before tax (PBT) for Q2 FY27 was Rs 32.80 cr, slightly higher than Rs 31.60 cr in Q2 FY26. Tax expense came in at Rs 8.20 cr, up from Rs 7.70 cr in the year-ago quarter. This resulted in profit after tax (PAT) of Rs 24.60 cr for Q2 FY27, compared with Rs 23.90 cr in Q2 FY26, as per the statement of financial results in the investor presentation.
Track Krsnaa Diagnostics Ltd
Cruxal reads every Krsnaa Diagnostics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
